incretin mimetics glp 1 agonists Drugs: GLP-1 Receptor Guide GLP-1 Analogues - How They

Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al

Comparative effectiveness of the sodiumglucose cotransporter 2 inhibitor empagliflozin versus other antihyperglycemics on risk of major adverse kidney events

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 19802017: a systematic analysis for the global burden of disease study 2017

European Journal of Clinical Nutrition

GLP-1RAs, specifically liraglutide, have also been evaluated for their effects on cardiovascular biomarkers

One of the most significant breakthroughs in MASLD and MASH targeted therapies is Resmetirom, an Food and Drug Administration (FDA)-approved agent for adults with noncirrhotic MASH with moderate to advanced fibrosis in conjunction to lifestyle therapy